2007”N
    ì‘åŠwˆãŠw•”•‘®•a‰@@–òÜ•”    
 
 

Œ¤‹†ŽÀÑ

   

EEE@2007”N@EEE

Šwp˜_•¶“™

Preventive Effects of Low-dose Dexamethasone for Delayed Adverse Events Induced by Carboplatin-based Combination Chemotherapy
Hitoshi KAWAZOE,Yoshiharu TAKIGUCHI,Hiroaki TANAKA,Chiaki DOI,Noriyasu FUKUOKA,Nobuhiro KANAJI,Shuji BANDOH,Toshihiko ISHIDA,Hitoshi HOUCHI
YAKUGAKU ZASSHI
127 (6) 1001-1006
2007

SERUM ALBUMIN LEVELS ANTICIPATE ANTITHROMBIN ‡V ACTIVITIES BEFORE AND AFTER ANTITHROMBIN ‡V AGENT IN CRITICAL PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
Mayuki Aibiki,Noriyasu Fukuoka,Kensuke umakoshi,Saori ohtsuboj and Satoshi Kikuchi
SHOCK
vol,27CN0,2
2007

ŒÂX‚ÌŠ³ŽÒ‚Ì•›ì—p—\‘ª‚Ì‚½‚߂ɊJ”­‚³‚ꂽ•wl‰È‚ª‚ñ‰»Šw—Ö@ƒ‚ƒjƒ^ƒŠƒ“ƒOƒV[ƒg
“y‹’q–¾,”ÑŒ´‚È‚¨‚Ý,‰Í“Y@m,•Ÿ‰ªŒ›‘×,–F’n@ˆê,•è—E“ñ,X“cC”V
YAKUGAKU ZASSHI
127 (6)
2007

“¯Ží‘¢ŒŒŠ²×–EˆÚAгŽÒ‚É‚¨‚¯‚éƒjƒ…[ƒLƒmƒƒ“ŒnR‹Û–ò‚É‚æ‚é“àˆö«Š´õ‚Ì—\–hŒø‰Ê\œ‘ˆÚA, ––½ŒŒŠ²×–EˆÚA, ä`‘ÑŒŒˆÚA‚Ì”äŠr\
‰Í“Y@m,‘êŒûË—ß,“c’†—TÍ,“ñ‹{¹Ž÷,•Ÿ‰ªŒ›‘×,‘å¼G–¾,Γcr•F,–F’n@ˆê
YAKUGAKU ZASSHI
127 (8)1301-1307
2007

‰@“à»ÜR¶•¨Ž¿“_Šá‰t‚̈À’è«
“c’†—TÍ,’©‘q³“o,“y‹’q–¾,‰Í“Y@m,•Ÿ‰ªŒ›‘×,‹Êˆä‰hŽ¡,‹{“c@–Î,¼‰º@Ž¡,‰ª•”º‰„,–F’n@ˆê
“ú–{•a‰@–òÜŽt‰ïŽGŽ
2007”N 43Šª 10†
2007

Differences in antithrombin III (AT) activities by administration method in critical patients with disseminated intravascular coagulation: A pharmacokinetic study
Mayuki Aibiki, Noriyasu Fukuoka, Takashi Nishiyama, Soichi Maekawa, Yoichi Shirakawa
SHOCK
vol.28
2007

Šw‰ï”­•\“™

“¯Ží‘¢ŒŒŠ²×–EˆÚAгŽÒ‚É‚¨‚¯‚éƒ^ƒNƒƒŠƒ€ƒX‚ÌŒŒ’†”Z“x‚ɑ΂·‚éƒ{ƒŠƒRƒiƒ][ƒ‹‚̉e‹¿,‰Í“Y@mA“c’†—TÍA•Ÿ‰ªŒ›‘×A‘å¼G–¾AΓcr•FA‘êŒûË—ßA–F’n@ˆê,‘æ29‰ñ“ú–{‘¢ŒŒ×–EˆÚAŠw‰ï‘‰ï,2007.2.16-17 •Ÿ‰ª

ƒEƒFƒ‹ƒVƒ…‹Û‚ÌŽå—v‚ȋۑ̊OƒvƒƒeƒA[ƒ[‚Ì«ó‰ð͂ƃmƒbƒNƒAƒEƒgŠ”ì» “c’†—TÍA‹Êˆä‰hŽ¡A‹{“c–ÎA¼‰ºŽ¡A–F’nˆêA‰ª•”º‰„,‘æ80‰ñ“ú–{׋ۊw‰ï‘‰ï,2007”N3ŒŽ26“ú@‘åã

“K³‚ȊȈՌœ‘÷–@‚ð–ÚŽw‚µ‚Äi4) \Œ»ó‚Ɖۑè\ ,›ˆé•”@–F]C_è@‹v”üŽqC—é–Ø@¹CŽR–{@•‘CŽO–Ø@’qdŽqC“y‹@’q–¾C”ÑŒ´@‚È‚¨‚ÝC“ñ‹{@¹Ž÷C•Ÿ‰ª@Œ›‘×C–F’n@ˆê,“ú–{–òŠw‰ï@‘æ127‰ñ”N‰ï,2007.3.29 •xŽR

“K³‚ȊȈՌœ‘÷–@‚ð–ÚŽw‚µ‚Äi3j \uŠÈˆÕŒœ‘÷–@ŠÄ¸ƒV[ƒgv“dŽq‰»‚Ö‚ÌŽŽ‚Ý\ ,›—é–Ø@¹C_è@‹v”üŽqCˆé•”@–F]C’J@‹v”üŽqC‰Á’n‰ëlC¬âM“ñC’ҔɎqC”ÑŒ´‚È‚¨‚ÝC•Ÿ‰ªŒ›‘×C–F’n@ˆê,“ú–{–òŠw‰ï@‘æ127‰ñ”N‰ï,2007.3.29 •xŽR

“K³‚ȊȈՌœ‘÷–@‚ð–ÚŽw‚µ‚Äi5j \ ‰@“à‚ł̘AŒg‘̧Šm—§‚ÌŽŽ‚Ý\ ,›_è@‹v”üŽqCˆé•”@–F]C—é–Ø@¹CŽO–Ø@‚ ‚©‚ËC‹v•Û@’q”üC“¡“c@ÍŽqCŒüˆä@‰hŽ¡C”ÑŒ´@‚È‚¨‚ÝC•Ÿ‰ª@Œ›‘×C–F’n@ˆê,“ú–{–òŠw‰ï@‘æ127‰ñ”N‰ï,2007.3.29 •xŽR

¸_‰Èƒ`[ƒ€‚É‚¨‚¯‚é•a“–òÜŽt‚Ì–ðŠ„ \ˆãŽtEŠÅŒìŽt‚̃Aƒ“ƒP[ƒg’²¸‚©‚ç\ ,›ŽÂŒ´@®Ž÷C‰Í“Y@mC–Ø‘º@ƒ•vC“¡ˆä@–rŽqCæ¼@^‘åC’©‘q@³“oC•Ÿ‰ª@Œ›‘×C–F’n@ˆê,“ú–{–òŠw‰ï‘æ127”N‰ïi•xŽRj@2007”N3/28A3/29A3/30 ,i•xŽRj@2007”N3/28A3/29A3/30

An aggressive report on PET-tracer synthesis at a pioneer hospital in Japan.,Masato Kaji, Masato Asakura, Shinji Kosaka, Hitoshi Kawazoe, Masaki Ninomiya, Noriyasu Fukuoka and Hitoshi Houchi,2007¢ŠE–òŠw‰ï‹c(Pharmaceutical sciences world congress),ƒIƒ‰ƒ“ƒ_@ƒAƒ€ƒXƒeƒ‹ƒ_ƒ€ 2007.4.22-25

Parmacokinetics of Tacrolimus and Mycophenolic Acid in Renal Transplant Recipients,Hiroaki Tanaka, Noriyasu Fukuoka, Masashi Inui, Rikiya Taoka, Kumiko Tani,Yuko Kawata, Chiaki Doi, Naoki Shinohara, Yoshiyuki Kakehi, Hitoshi Houchi,‘æ3‰ñ@¢ŠE–òŠw‰ï‹ciPharmaceutical Sciences World Congressj ,2007”N4ŒŽ22-25 ƒIƒ‰ƒ“ƒ_@ƒAƒ€ƒXƒeƒ‹ƒ_ƒ€

tˆÚAгŽÒ‚É‚¨‚¯‚éƒ^ƒNƒƒŠƒ€ƒX‚Ì‘Ì“à“®‘ԂƖƉu—}§Œø‰Ê‚Ƃ̊֌W,•Ÿ‰ªŒ›‘×A’J‹v”üŽqA“c’†—TÍAŠ£@­ŽuA“c‰ª—˜‹X–çA–k‘º—IŽ÷A–î–ì•qŽjA‰ª“Y—_A’JŒû@iAíXаsA’Ï@•¶•vA™–{вŽjAâ¨@‘PsA–F’n@ˆê@,‘æ25‰ñ’†‘Žl‘—Õ°‘ŸŠíˆÚAŒ¤‹†‰ï,2007”N8ŒŽ ¼]

Impact of Tacrolimus after the Switch from Fluconazole to Voriconazole in Patients Receiving Allo-stem Cell Transplant,‰Í“Y@m, “c’†—TÍ, •Ÿ‰ªŒ›‘×, ‘å¼G–¾, Γcr•F, ‘êŒûË—ß, –F’nˆê ,‘æ17‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï ŒQ”n, 09.29-30, 2007

ƒEƒGƒ‹ƒVƒ…‹Û‚̃vƒƒeƒA[ƒ[‚“xŽY¶Š”‚Ì—˜—p‚ɂ‚¢‚Ä The utility of protease-high producing strain of Clostridium perfringens,›“c’†—TÍA‹Êˆä‰hŽ¡A^“ç’å•vA¬’JG•¶A‹{“c@–ÎA–F’n@ˆêA‰ª•”º‰„,“ú–{׋ۊw‰ï’†‘EŽl‘Žx•”‘‰ï,•½¬19”N10ŒŽ14“ú ‰ªŽR

Comparison of Preventive Effects of Newquinolones for Infection in Patients Receiving Various Allogeneic Transplantation,‰Í“Y@m, ‘å¼G–¾, –F’n@ˆê,‘æ66‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï ‰¡•l, 10.03-05, 2007.

ŠÖßƒŠƒEƒ}ƒ`гŽÒ‚ɑ΂·‚éƒ^ƒNƒƒŠƒ€ƒX‚ÌŒŒ’†”Z“x‚Æ—LŒø«‚ÌŒŸ“¢,‰Í“Y@m, “y‹´_Í, “c’†—TÍ, ’J‹v”üŽq, •Ÿ‰ªŒ›‘×, ‹T“c’qL, F茫‘¾˜Y, ‹k‚ŽŽ¡, Γcr•F, –F’n@ˆê,‘æ18‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï’†‘EŽl‘Žx•”ŠwpW‰ï ‰ªŽR, 10.13, 2007.

Šà‰»Šw—Ö@‚ÌŽxŽ—Ã–@‚É‚¨‚¯‚é•a“–òÜŽt‚̉î“ü`’x‰„«ˆ«SEšq“f‚ɑ΂·‚éƒfƒLƒTƒƒ^ƒ]ƒ“`,‰Í“Y@m, “c’†—TÍ, •Ÿ‰ªŒ›‘×, ‹à’nM‘ñ, ⓌC“ñ, Γc r•F, ‘êŒûË—ß, –F’nˆê,‘æ46‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï ’†‘Žl‘Žx•”Šwp‘å‰ï,‚’m 2007.11.10`11

–òÜ•”‚ł̖³‹Û’²®‚ÉŠÖ‚í‚éˆã—ÃÞ—¿”ï‚ÌŒŸ“¢ -8”N‘O‚Æ”äŠr‚µ‚Ä-,“¡ˆä–rŽqC•Ÿ‰ªŒ›‘×,–F’n@ˆê,‘æ46‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï ’†‘Žl‘Žx•”Šwp‘å‰ï,‚’m 2007.11.10 ‚’mŽs•¶‰»ƒvƒ‰ƒUu‚©‚é‚Û[‚Æv

ŠJ• ŽèpгŽÒ‚É‚¨‚¯‚é• o“àPK-PDƒ‚ƒjƒ^ƒŠƒ“ƒO‚ÉŠî‚­cefepime‚Ì“Š—^•û–@‚ÌŽŠ“K‰»,”óŒû˜aŽqA’–ì˜a˜NA’r“c‰À‘ãA‘å–ÑGŠìA––“c‘דñ˜YA–F’n@ˆêAXì‘¥•¶,‘æ28‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï,2007”N11ŒŽ30“ú “È–ØŒ§

•a‰@–òÜŽt‚Ì—§ê‚©‚ç‚n‚r‚b‚d‚ÉŠú‘Ò‚·‚邱‚Æ,•Ÿ‰ªŒ›‘×,‘æ46‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï@’†‘Žl‘Žx•”Šwp‘å‰ï,•½¬19”N11ŒŽ11“ú(“ú) ‚’mŽs

ƒjƒ…[ƒLƒmƒƒ“‚Æ‹à‘®ŠÜ—L»Ü‚Ì‘ŠŒÝì—p‚ð—˜—p‚µ‚½’°“àŽE‹Û—Ö@,‰Í“Y@m, ‚‰ª@‹±Žq, ˆ¢•”@^”Ž, ŽÄ“c@—m•¶, VŠ_@®·, ”óŒû@•x•F, –F’n@ˆê, “y‰®@_ˆê˜Y, ‘êŒû@Ë—ß,‘æ28‰ñ“ú–{—Õ°–ò—Šw‰ï”N‰ï,“È–Ø, 11.28-12.01, 2007.

¸_‰Èƒ`[ƒ€‚É‚¨‚¯‚é•a“–òÜŽt‚Ì–ðŠ„ \ˆãŽtEŠÅŒìŽt‚̃Aƒ“ƒP[ƒg’²¸‚©‚çi‘OŒã”äŠrj\ ,›ŽÂŒ´@®Ž÷C‰Í“Y@mC–Ø‘º@ƒ•vCæ¼@^‘åC’©‘q@³“oC“ñ‹{@¹Ž÷C•Ÿ‰ª@Œ›‘×C–F’n@ˆê ,’†‘Žl‘–ò•¨—Ö@‰ï@,i‚’mj@2007”N11/10

“¯Ží‘¢ŒŒŠ²×–EˆÚAгŽÒ‚É‚¨‚¯‚éƒ^ƒNƒƒŠƒ€ƒX‚ÌŒŒ’†”Z“x‚ÉR^‹Û–ò•ÏX‚ª‹y‚Ú‚·‰e‹¿,ŽRŒû@‰À’ËRC•Ÿ‰ªŒ›‘×,–F’n@ˆê,‘æ46‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï@’†‘Žl‘Žx•”Šwp‘å‰ï,•½¬19”N11ŒŽ11“ú(“ú) ‚’mŽs

“¯Ží‘¢ŒŒŠ²×–EˆÚAгŽÒ‚É‚¨‚¯‚éƒjƒ…[ƒLƒmƒƒ“‚Ì—\–h“Š—^‚̉e‹¿,ˆäã’B–çC•Ÿ‰ªŒ›‘×,–F’n@ˆê,‘æ46‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï@’†‘Žl‘Žx•”Šwp‘å‰ï,•½¬19”N11ŒŽ11“ú(“ú) ‚’mŽs

Copyright(1997-2012)reserved by DEPARTMENT OF PHARMACY,KAGAWA UNIVERSITY HOSPITAL